-
H&E-based Computational Biomarker Enables Universal EGFR Screening for Lung Adenocarcinoma
Authors:
Gabriele Campanella,
David Ho,
Ida Häggström,
Anton S Becker,
Jason Chang,
Chad Vanderbilt,
Thomas J Fuchs
Abstract:
Lung cancer is the leading cause of cancer death worldwide, with lung adenocarcinoma being the most prevalent form of lung cancer. EGFR positive lung adenocarcinomas have been shown to have high response rates to TKI therapy, underlying the essential nature of molecular testing for lung cancers. Despite current guidelines consider testing necessary, a large portion of patients are not routinely pr…
▽ More
Lung cancer is the leading cause of cancer death worldwide, with lung adenocarcinoma being the most prevalent form of lung cancer. EGFR positive lung adenocarcinomas have been shown to have high response rates to TKI therapy, underlying the essential nature of molecular testing for lung cancers. Despite current guidelines consider testing necessary, a large portion of patients are not routinely profiled, resulting in millions of people not receiving the optimal treatment for their lung cancer. Sequencing is the gold standard for molecular testing of EGFR mutations, but it can take several weeks for results to come back, which is not ideal in a time constrained scenario. The development of alternative screening tools capable of detecting EGFR mutations quickly and cheaply while preserving tissue for sequencing could help reduce the amount of sub-optimally treated patients. We propose a multi-modal approach which integrates pathology images and clinical variables to predict EGFR mutational status achieving an AUC of 84% on the largest clinical cohort to date. Such a computational model could be deployed at large at little additional cost. Its clinical application could reduce the number of patients who receive sub-optimal treatments by 53.1% in China, and up to 96.6% in the US.
△ Less
Submitted 21 June, 2022;
originally announced June 2022.
-
PHiSeg: Capturing Uncertainty in Medical Image Segmentation
Authors:
Christian F. Baumgartner,
Kerem C. Tezcan,
Krishna Chaitanya,
Andreas M. Hötker,
Urs J. Muehlematter,
Khoschy Schawkat,
Anton S. Becker,
Olivio Donati,
Ender Konukoglu
Abstract:
Segmentation of anatomical structures and pathologies is inherently ambiguous. For instance, structure borders may not be clearly visible or different experts may have different styles of annotating. The majority of current state-of-the-art methods do not account for such ambiguities but rather learn a single mapping from image to segmentation. In this work, we propose a novel method to model the…
▽ More
Segmentation of anatomical structures and pathologies is inherently ambiguous. For instance, structure borders may not be clearly visible or different experts may have different styles of annotating. The majority of current state-of-the-art methods do not account for such ambiguities but rather learn a single mapping from image to segmentation. In this work, we propose a novel method to model the conditional probability distribution of the segmentations given an input image. We derive a hierarchical probabilistic model, in which separate latent variables are responsible for modelling the segmentation at different resolutions. Inference in this model can be efficiently performed using the variational autoencoder framework. We show that our proposed method can be used to generate significantly more realistic and diverse segmentation samples compared to recent related work, both, when trained with annotations from a single or multiple annotators.
△ Less
Submitted 26 July, 2019; v1 submitted 7 June, 2019;
originally announced June 2019.
-
Adversarial Augmentation for Enhancing Classification of Mammography Images
Authors:
Lukas Jendele,
Ondrej Skopek,
Anton S. Becker,
Ender Konukoglu
Abstract:
Supervised deep learning relies on the assumption that enough training data is available, which presents a problem for its application to several fields, like medical imaging. On the example of a binary image classification task (breast cancer recognition), we show that pretraining a generative model for meaningful image augmentation helps enhance the performance of the resulting classifier. By au…
▽ More
Supervised deep learning relies on the assumption that enough training data is available, which presents a problem for its application to several fields, like medical imaging. On the example of a binary image classification task (breast cancer recognition), we show that pretraining a generative model for meaningful image augmentation helps enhance the performance of the resulting classifier. By augmenting the data, performance on downstream classification tasks could be improved even with a relatively small training set. We show that this "adversarial augmentation" yields promising results compared to classical image augmentation on the example of breast cancer classification.
△ Less
Submitted 20 February, 2019;
originally announced February 2019.
-
Injecting and removing malignant features in mammography with CycleGAN: Investigation of an automated adversarial attack using neural networks
Authors:
Anton S. Becker,
Lukas Jendele,
Ondrej Skopek,
Nicole Berger,
Soleen Ghafoor,
Magda Marcon,
Ender Konukoglu
Abstract:
$\textbf{Purpose}$ To train a cycle-consistent generative adversarial network (CycleGAN) on mammographic data to inject or remove features of malignancy, and to determine whether these AI-mediated attacks can be detected by radiologists. $\textbf{Material and Methods}…
▽ More
$\textbf{Purpose}$ To train a cycle-consistent generative adversarial network (CycleGAN) on mammographic data to inject or remove features of malignancy, and to determine whether these AI-mediated attacks can be detected by radiologists. $\textbf{Material and Methods}$ From the two publicly available datasets, BCDR and INbreast, we selected images from cancer patients and healthy controls. An internal dataset served as test data, withheld during training. We ran two experiments training CycleGAN on low and higher resolution images ($256 \times 256$ px and $512 \times 408$ px). Three radiologists read the images and rated the likelihood of malignancy on a scale from 1-5 and the likelihood of the image being manipulated. The readout was evaluated by ROC analysis (Area under the ROC curve = AUC). $\textbf{Results}$ At the lower resolution, only one radiologist exhibited markedly lower detection of cancer (AUC=0.85 vs 0.63, p=0.06), while the other two were unaffected (0.67 vs. 0.69 and 0.75 vs. 0.77, p=0.55). Only one radiologist could discriminate between original and modified images slightly better than guessing/chance (0.66, p=0.008). At the higher resolution, all radiologists showed significantly lower detection rate of cancer in the modified images (0.77-0.84 vs. 0.59-0.69, p=0.008), however, they were now able to reliably detect modified images due to better visibility of artifacts (0.92, 0.92 and 0.97). $\textbf{Conclusion}$ A CycleGAN can implicitly learn malignant features and inject or remove them so that a substantial proportion of small mammographic images would consequently be misdiagnosed. At higher resolutions, however, the method is currently limited and has a clear trade-off between manipulation of images and introduction of artifacts.
△ Less
Submitted 19 November, 2018;
originally announced November 2018.
